4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-034694
Director acquired 16,862 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GAROFALO ELIZABETH A. Director | 2022-06-07 | Option exercise | +6,391 | 8,309 | D | ||
| GAROFALO ELIZABETH A. Director | 2022-09-29 | Option exercise | +1,919 | 10,228 | D | ||
| GAROFALO ELIZABETH A. Director | 2023-06-01 | Option exercise | +8,552 | 18,780 | D | ||
| Derivatives | |||||||
| GAROFALO ELIZABETH A. Director | 2022-06-07 | Option exercise · Restricted Stock Units | −6,391 | 0 | D | ||
| GAROFALO ELIZABETH A. Director | 2022-09-29 | Option exercise · Restricted Stock Units | −1,919 | 0 | D | ||
| GAROFALO ELIZABETH A. Director | 2023-06-01 | Option exercise · Restricted Stock Units | −8,552 | 0 | D | ||
| GAROFALO ELIZABETH A. Director | 2023-06-01 | Grant or award · Director Stock Options (Right to Buy) | +11,045 | 11,045 | D | ||
| GAROFALO ELIZABETH A. Director | 2023-06-01 | Grant or award · Restricted Stock Units | +6,652 | 6,652 | D | ||
Loading xslF345X04/doc4.xml…